Latest News

OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Cycloate.

OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Paclobutrazol.

OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Abamectin.

This regulation adopts "no significant risk" levels in Section 12705, subsection (b), for the following chemicals: Arsenic, Butylated hydroxyanisole, Cadmium, and Chromium (hexavalent compounds). 

The purpose of this regulation is to provide "safe harbor" no significant risk levels for dichloromethane (methylene chloride), trichloroethylene, and vinyl chloride.

This regulation adopts "no significant risk" levels for Hexachlorodibenzodioxin (HCDD) of 0.0002 microgram per day and 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) of 0.000005 microgram per day. 

The purpose of this regulation is to provide "safe harbor" no significant risk levels for an additional 140 chemicals, below which the Act does not apply. 

This regulation adopts no significant risk levels for Benzyl chloride of 4 micrograms per day and Bromodichloromethane of 5 micrograms per day. 

OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Abamectin.

OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Malathion, Chlorpyrifos, and Bensulfuron Methyl.